Delivery Order SPE2DB22D1103-SPE2DB24FTNB4
Award Date
7/3/24
Potential Completion Date
7/5/24
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,187.20, is for the delivery of Lantus SoloStar 100 unit/ml 3ml, a prescription insulin medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of November 5, 2021. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,958.74 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at up to $2,375.20, is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a prescription insulin product. The contract has a period of performance through June 12, 2024 and is classified as a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,992.84 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of Lantus Solostar 100 unit/ml 3ml, a prescription insulin medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of Lantus SoloStar 100 unit/ml 3ml, a type of insulin medication. The contract, valued at $1,596.51, was awarded by the Defense Logistics Agency (DLA) on July 3, 2024, with a completion date of July 5, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds two Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,225.06 firm fixed-price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used to treat diabetes. The contract has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a delivery order contract to the Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Lantus Solostar 100 unit/ml 3ml insulin medication. The $2,280.56 firm fixed price contract has a completion date of July 1, 2024. Amerisourcebergen is the prime contractor for this award, which is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $1,187.60, is for the delivery of Lantus Solostar 100 unit/mL 3mL, a type of insulin medication. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,068.84 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the provision of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used to treat diabetes. This award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lantus Solostar 100 unit/ml 3ml insulin delivery devices. The contract has a ceiling value of $1,227.36 and a period of performance through January 22, 2025. It is a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...